• The Company
    • Who we are
    • Partner Portal
  • Meet the Partners
  • Our Approach
  • Portfolio
    • Current Portfolio
    • Historic Portfolio
  • News
  • Contact Us
The Vertical Group
Investing for Innovation

Improving Stroke Recovery MicroTransponder Vivistim Paired VNS System

10/28/2023

 
Via: ​time.com
​MicroTransponder’s Vivistim Paired VNS system is a chest implant that helps chronic ischemic stroke survivors regain impaired motor function in their arms and hands by stimulating the nearby vagus nerve, the body’s “superhighway” of electrical signals. It’s the first product to do so for strokes, earning it the FDA’s breakthrough device designation. Vivistim works to boost the effects of physical therapy, facilitating the development of strength and dexterity at two to three times the degree of recovery without it. “We can implant something, and six weeks later, people are having clinically improved benefits,” MicroTransponder CEO Richard Foust says.

Read More: https://time.com/collection/best-inventions-2023/6324373/microtransponder-vivistim-paired-vns-system/

Radiaction Medical Appoints Christopher Barys as United States President and Chief Commercial Officer

10/24/2023

 
Via: Endovascular Today
Radiaction Medical, LTD, an Israel-based medical device company focused on radiation protection for medical staff during interventional procedures, announced that it has appointed industry veteran Christopher Barys to serve as its United States President and Chief Commercial Officer. Barys will lead commercialization efforts and operations in the United States.

Radiaction is a plug-and-play addition to C-arm systems that blocks up to 97% of scatter radiation at the source, offering head-to-toe protection for everyone in the room. Radiaction has received CE Mark approval in Europe and FDA clearance in the United States and is currently being marketed in North America.

Read More: ​https://evtoday.com/news/radiaction-medical-appoints-christopher-barys-as-united-states-president-and-chief-commercial-officer

Luminopia Named to TIME’s List of the Best Inventions of 2023

10/24/2023

 
Via: Business Wire
Luminopia, Inc., a commercial-stage company pioneering a new class of treatments for neuro-visual disorders, today announced that the company’s lead product, Luminopia, was named one of TIME’s Best Inventions of 2023.

Luminopia is the first FDA-approved1 digital therapeutic for a neuro-visual disorder, indicated to improve vision in children, aged 4-7, with amblyopia (lazy eye). Amblyopia is the leading cause of vision loss in children, affecting 3% of children worldwide. Traditional treatments include glasses, eye-patches, and blurring (atropine) eye drops, but these options leave a significant unmet need due to poor compliance, residual vision loss, and negative psychosocial impacts.

Read More: ​https://www.businesswire.com/news/home/20231024543829/en/Luminopia-Named-to-TIME%E2%80%99s-List-of-the-Best-Inventions-of-2023

TRACE MEDICAL TO DISTRIBUTE HOME DIALYSIS SYSTEM

10/4/2023

 
Via: HME News 
WHITMORE LAKE, Mich. – Trace Medical has signed a long-term distribution agreement with Outset Medical to rent the Tablo Hemodialysis System to HME providers to meet the growing demand of dialysis patients seeking treatment at home. “We are excited to work with Outset to fill an obvious need in dialysis treatment,” said Greg Apostolou, CEO. “Our chairman was recently diagnosed with renal disease and experienced first-hand the treatment gaps for patients. Together, we see an opportunity for Trace to utilize our national distribution platform and customer base, which serves approximately 30 million patients annually, to address these gaps.” Tablo, cleared by the U.S. Food and Drug Administration, serves as a single enterprise solution that can be used across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. “Home hemodialysis is the future of dialysis care,” said Steve Williamson, chief commercial officer, Outset Medical. “This new agreement will provide us an additional opportunity to reach the over half million Americans that depend on dialysis to live.” Trace has established a Dialysis Advisory Board with some of the industry’s most prominent nephrologists, GPO leaders and C-suite executives to help educate the industry about the benefits of home hemodialysis and has initiated discussions with commercial payer related to the clinical and financial benefits associated with home hemodialysis.

Read More: https://www.hmenews.com/article/trace-medical-to-distribute-home-dialysis-system

Trace Medical & Outset Medical sign long-term distribution agreement for Tablo® Hemodialysis System

10/3/2023

 
Via: Business Wire
As part of this agreement, Trace Medical will leverage its national distribution network to offer HME providers exclusive access to rent Tablo and meet the growing demand of dialysis patients seeking treatment at home. Greg Apostolou, Chief Executive Officer of Trace Medical, stated, “We are excited to work with Outset to fill an obvious need in dialysis treatment. Our chairman was recently diagnosed with renal disease and experienced first-hand the treatment gaps for patients. Together, we see an opportunity for Trace to utilize our national distribution platform and customer base which serves approximately 30 million patients annually to address these gaps. After months of planning with the talented team at Outset Medical, we are confident in our collective abilities to serve all healthcare channels with Tablo and make a meaningful difference in patient experience and clinical outcomes.”

​Read More: ​https://www.businesswire.com/news/home/20231004237474/en/Trace-Medical-Outset-Medical-sign-long-term-distribution-agreement-for-Tablo%C2%AE-Hemodialysis-System

Bringing Innovative Dialysis Care to a Long-Term Acute Care (LTAC) Hospital in Rural Northern California

9/30/2023

 
Via: Outset
Vibra Hospital of Northern California in Redding is the only long-term acute care (LTAC) hospital in the rural region of the West Coast stretching from north of Sacramento to south of Portland, OR. Care for dialysis patients at this specialty facility is particularly problematic, with only three nephrologists serving the entire area, a growing end-stage renal disease (ESRD) population and patients and their families often having to drive far distances for outpatient intermittent hemodialysis (IHD).

Recently, Vibra Healthcare’s corporate leadership decided to bring in-house IHD services, featuring Outset Medical’s first-of-its-kind Tablo® Hemodialysis System, to several of its hospitals including Vibra Hospital of Northern California. Vibra Hospital of Northern California started managing its own Tablo program in December of 2022.

Read More: ​https://www.outsetmedical.com/perspective/innovative-dialysis-care-in-a-long-term-acute-care-hospital/

ASA seeks to ‘empower’ Hispanic-Latino communities with promotion of RÁPIDO acronym

9/21/2023

 
Via: Neuro News
To help “close the gap between knowledge and action”, the American Stroke Association (ASA) is launching a culturally relevant Spanish-language campaign named ‘Juntos Contra el Derrame Cerebral’ to raise awareness among Spanish-dominant audiences around the use and understanding of RÁPIDO—a Spanish acronym for stroke warning signs.

According to ASA stroke survey data, only 39% of Hispanic-Latino consumers said they were familiar with the English stroke warning sign acronym, FAST, and only 42% could correctly name two stroke warning signs unaided.

Hispanic-Latino adults in the USA have a higher risk of stroke due to unmanaged risk factors, limited access to healthcare, lower health literacy rates, cultural barriers and socioeconomic determinants of health. That is according to a press release from the ASA, a division of the American Heart Association (AHA). Hispanic-Latino stroke patients also have longer delay times to hospital arrival than non-Hispanic stroke patients, as well as greater stroke severity and poorer outcomes following stroke.

Read More: ​https://neuronewsinternational.com/asa-seeks-to-empower-hispanic-latino-communities-with-promotion-of-rapido-acronym/

Global report on hypertension

9/19/2023

 
Via: World Health Organization
The race against a silent killer

To amplify the stark reality of the disease burden from this "silent killer", WHO produced a Global report on hypertension. This comprehensive report features unsettling statistics underscoring the far-reaching consequences of uncontrolled hypertension – ranging from heart attacks, strokes and premature death to substantial economic loss.  Moreover, the accompanying profiles offer a country-by-country snapshot of hypertension burden and control. The report not only serves as an eye-opener but also shows the way forward for countries to protect their people, highlighting the tremendous strides made in managing the disease, and drawing insights from the implementation of the WHO HEARTS package. Additionally, it equips countries with essential tools to enhance hypertension prevention, control and surveillance, thereby offering a roadmap towards a healthier future.

Read More: https://www.who.int/teams/noncommunicable-diseases/hypertension-report

UNITED NATIONS ECONOMIC AND SOCIAL COUNCIL GRANTS SPECIAL CONSULTATIVE STATUS UPON SVIN

8/31/2023

 
Via: SVIN
Washington, D.C., August 31, 2023 — The Society of Vascular and Interventional Neurology (SVIN) and its Mission Thrombectomy Committee (SVIN_MT) proudly announce a momentous achievement. On August 8, 2023, the esteemed United Nations Economic and Social Council (ECOSOC) granted SVIN the prestigious special consultative status.

SVIN is thrilled to herald a new chapter in its journey, what it means for its members and affiliations, to advance global conversations and patient access to thrombectomy. It positions SVIN at the forefront of organizations collaborating with ECOSOC, opening doors to impactful interactions with subsidiary bodies, including the Human Rights Council. Moreover, this status facilitates participation in select General Assembly meetings and other intergovernmental gatherings, fostering collaborative exchanges with the United Nations Secretariat.

This status underscores SVIN's dedication to making a tangible difference on a global scale, opening the doors to impactful dialogues, critical collaborations, and valuable partnerships that align with SVIN's mission to advance vascular and interventional neurology for the betterment of global healthcare.

Read More: https://www.svin.org/i4a/headlines/headlinedetails.cfmcontroller=headlines&action=headlineDetails&id=86&categoryID=0&startVal=1

Mahesh Jayaraman becomes 28th president of the Society of NeuroInterventional Surgery

8/29/2023

 
Via: Neuro News
Mahesh Jayaraman, an interventional neuroradiologist at Rhode Island Hospital in Providence, USA—who has led national efforts to improve stroke systems of care in the USA—has been named the 2023 president of the Society of NeuroInterventional Surgery (SNIS), a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery.

As president, Jayaraman will lead the SNIS in all its endeavours to enhance the field, according to a press release. SNIS members work to promote research, standard-setting, education and advocacy regarding diagnosing and treating diseases of the brain, spine, head, and neck. With more than 1,000 members worldwide, the society is committed to providing the highest quality of patient care through these minimally invasive procedures, the release adds.

Read More: https://neuronewsinternational.com/mahesh-jayaraman-becomes-28th-president-of-the-society-of-neurointerventional-surgery/
<<Previous

    Archives

    October 2023
    September 2023
    September 2022
    August 2022
    June 2022
    May 2022
    February 2022
    January 2022
    December 2021
    May 2021
    April 2021
    February 2021
    January 2021
    December 2020
    November 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    December 2019
    November 2019
    October 2019
    August 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    April 2015
    March 2015
    February 2015
    January 2015
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    February 2014
    January 2014
    December 2013
    October 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013

    RSS Feed

© The Vertical Group - [email protected]
 PO 218, Berkeley Heights, NJ 07922 | (908) 277-3737
PO 5006, San Mateo, CA  94402 | (650) 566-9060
Picture
Website by Custom Dynamics